X-ray Structure-Guided Discovery of a Potent, Orally Bioavailable, Dual Human Indoleamine/Tryptophan 2,3-Dioxygenase (hIDO/hTDO) Inhibitor That Shows Activity in a Mouse Model of Parkinson's Disease.

Journal of Medicinal Chemistry
Xiang-Li NingGuo-Bo Li

Abstract

Human indoleamine 2,3-dioxygenase 1 (hIDO1) and tryptophan 2,3-dioxygenase (hTDO) have been closely linked to the pathogenesis of Parkinson's disease (PD); nevertheless, development of dual hIDO1 and hTDO inhibitors to evaluate their potential efficacy against PD is still lacking. Here, we report biochemical, biophysical, and computational analyses revealing that 1H-indazole-4-amines inhibit both hIDO1 and hTDO by a mechanism involving direct coordination with the heme ferrous and ferric states. Crystal structure-guided optimization led to 23, which manifested IC50 values of 0.64 and 0.04 μM to hIDO1 and hTDO, respectively, and had good pharmacokinetic properties and brain penetration in mice. 23 showed efficacy against the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse motor coordination deficits, comparable to Madopar, an anti-PD medicine. Further studies revealed that different from Madopar, 23 likely has specific anti-PD mechanisms involving lowering IDO1 expression, alleviating dopaminergic neurodegeneration, reducing inflammatory cytokines and quinolinic acid in mouse brain, and increasing kynurenic acid in mouse blood.

References

Sep 1, 1992·Neurology·T OgawaS Saso
Jun 6, 1995·Proceedings of the National Academy of Sciences of the United States of America·P M MoranP C Moser
Mar 30, 2001·Neuroreport·A SantamaríaF St'astný
Jun 22, 2002·Journal of Neural Transmission·B WidnerD Fuchs
Nov 5, 2002·Biopharmaceutics & Drug Disposition·J Cory Kalvass, Tristan S Maurer
Jun 24, 2003·Angewandte Chemie·Chandrakala PidathalaBenjamin List
Oct 14, 2003·Drug Discovery Today·David E Clark
Nov 24, 2004·Proceedings of the National Academy of Sciences of the United States of America·Pascal AuffingerP Shing Ho
Jul 6, 2011·Journal of Medicinal Chemistry·Eduard DolusićRaphaël Frédérick
Feb 7, 2012·Proceedings of the National Academy of Sciences of the United States of America·Luc PilotteBenoît J Van den Eynde
Jun 9, 2012·Nature Reviews. Neuroscience·Robert SchwarczHui-Qiu Wu
Feb 9, 2013·Neurochemistry International·Mohammad Moshahid KhanAsgar Zaheer
Oct 28, 2014·Frontiers in Immunology·Helen J BallHajime J Yuasa
Mar 17, 2015·Seminars in Cell & Developmental Biology·Daniel C Maddison, Flaviano Giorgini
Apr 2, 2015·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Mojtaba GolpichAbolhassan Ahmadiani
Apr 27, 2016·Proceedings of the National Academy of Sciences of the United States of America·Carlo BredaFlaviano Giorgini
Jun 20, 2017·Journal of Neurochemistry·Jesper F HavelundJan Bert Gramsbergen
Jul 1, 2017·Journal of Chemical Information and Modeling·Guo-Bo LiSheng-Yong Yang
Nov 24, 2017·Nature Communications·Ariel Lewis-BallesterSyun-Ru Yeh
Mar 10, 2018·Current Pharmaceutical Biotechnology·Rao MukkavilliSubrahmanyam Vangala
Mar 14, 2018·Proceedings of the National Academy of Sciences of the United States of America·Micah T NelpJohn T Groves
May 26, 2018·ACS Medicinal Chemistry Letters·Zhonghua PeiBenjamin D Sellers
Jun 14, 2018·Journal of the American Chemical Society·Ariel Lewis-BallesterSyun-Ru Yeh
Jun 15, 2018·Cell Host & Microbe·Allison AgusHarry Sokol
Sep 29, 2018·Nature Reviews. Drug Discovery·Delphine CharvinOlivier Rascol
Oct 24, 2018·Journal of the American Chemical Society·Khoa N Pham, Syun-Ru Yeh
Nov 2, 2018·Science Translational Medicine·Richard GordonTrent M Woodruff

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.